Fairfield, Bush & Co’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,400
Closed -$254K 162
2021
Q1
$254K Buy
+1,400
New +$325K 0.07% 144

Other funds holding TDOC

Fairfield, Bush & Co's TDOC Position: Q2 2021 in Review

Fairfield, Bush & Co sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 1,400 shares — an estimated $254K sold.

Fairfield, Bush & Co first reported a position in TDOC in Q1 2021 and held it in 1 quarter. The position peaked at $254K in Q1 2021. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Fairfield, Bush & Co reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Fairfield, Bush & Co sold 1,400 Teladoc Health shares in Q2 2021, an estimated $254K.
  • Fairfield, Bush & Co first reported a position in Teladoc Health in Q1 2021 and held it in 1 quarter.
  • Fairfield, Bush & Co's Teladoc Health position peaked at $254K in Q1 2021.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Fairfield, Bush & Co's 13F filing for Q2 2021, filed 2 Aug 2021.